MedPath

Ayurvedic Management of Sandhivata

Phase 1
Not yet recruiting
Conditions
Bilateral primary osteoarthritis of knee,
Registration Number
CTRI/2020/08/027462
Lead Sponsor
Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur
Brief Summary

IT IS A RANDOMIZED PARALLEL GROUP CLINICAL TRIAL OF 30 PATIENTS WHICH ARE DIVIDED IN 2 GROUPS CONSISTS OF 15 PATIENTS.FIRST GROUP WILL BE TREATED WITH MEDICINE PRESCRIBED IN O.P.D/I.P.D AND SVEDENA AND VIMLAPANA KARMA ON JANU AND SAKTHIGATA ANI MARMA WHILE SECOND GROUP WILL BE TREATED WITH ONLY SVEDENA AND VIMLAPNA KARMA.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

patients having classical features of sandhishoola,sandhishotha,sthabdhata and sparshaasahyta.

Exclusion Criteria

patients having severe disease like cardiac disease,pulmonary tuberculosis,diabetes,renal function impairment,raised value of serum uric acid than normal value,extreme reduce in joints,chronicity of sandhigatavatavata more than 5years.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
improvement in subjective and objective critria45 days
Secondary Outcome Measures
NameTimeMethod
to find efficacy of vimlapana and svedena karma with mahavisgarbh tail in sandhivata45 days

Trial Locations

Locations (1)

Dr. Sarvepalli Radhakrishnan rajasthan Ayurved University, University Hospital of Ayurved

🇮🇳

Jodhpur, RAJASTHAN, India

Dr. Sarvepalli Radhakrishnan rajasthan Ayurved University, University Hospital of Ayurved
🇮🇳Jodhpur, RAJASTHAN, India
Dr Mahendra Sharma
Principal investigator
9166191561
vdmahendrasharma@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.